Clinical Trial Update: Avelox in Complicated Skin and Skin Structure Infections

View source ↗

Summary

A Bayer-sponsored trial evaluating moxifloxacin (Avelox) for complicated skin and skin structure infections has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Skin and Soft Tissue Infections

Drugs mentioned

• Avelox (moxifloxacin)

Snippet

Sponsor: Bayer | Conditions: Skin Diseases, Bacterial | Status: COMPLETED